Тромбоэмболические осложнения у пациентов с воспалительными заболеваниями кишечника
- Авторы: Лищинская А.А1, Каграманова А.В1, Звяглова М.Ю1, Князев О.В1, Фадеева Н.А1, Кулаков Д.С1, Парфенов А.И1
-
Учреждения:
- Московский клинический научно-практический центр им. А.С. Логинова ДЗ Москвы
- Выпуск: Том 26, № 2 (2019)
- Страницы: 10-19
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/296679
- DOI: https://doi.org/10.18565/pharmateca.2019.2.10-19
- ID: 296679
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Полный текст
Об авторах
А. А Лищинская
Московский клинический научно-практический центр им. А.С. Логинова ДЗ Москвы
Email: lalbina@inbox.ru
к.м.н., старший науч. сотр. отделения воспалительных заболеваний кишечника
А. В Каграманова
Московский клинический научно-практический центр им. А.С. Логинова ДЗ Москвы
М. Ю Звяглова
Московский клинический научно-практический центр им. А.С. Логинова ДЗ Москвы
О. В Князев
Московский клинический научно-практический центр им. А.С. Логинова ДЗ Москвы
Н. А Фадеева
Московский клинический научно-практический центр им. А.С. Логинова ДЗ Москвы
Д. С Кулаков
Московский клинический научно-практический центр им. А.С. Логинова ДЗ Москвы
А. И Парфенов
Московский клинический научно-практический центр им. А.С. Логинова ДЗ Москвы
Список литературы
- Fumery M., Xiaocang C., Dauchet L., et ai. Thromboembolic events and cardiovascular mortality in inflammatory bowel diseases: a meta-anaiysis of observational studies. J Crohns Colitis. 2014;8:469-79. Doi: 10.1016/j. crohns.2013.09.021.
- Yoshida H., Granger D.N. Inflammatory bowel disease: a paradigm for the link between coagulation and inflammation. Inflamm. Bowel Dis. 2009;15:1245-55.
- Bargen J.A., Barker N.W. Extensive arterial and venous thrombosis complicating chronic ulcerative colitis. Arch intern Med. 1936;58:17-31. doi: 10.1001/archinte.1936.00170110025002.
- Talbot R.W., Heppell J., Dozois R.R., Beart R.W. Vascular complications of inflammatory bowel disease. Mayo Clin Proc. 1986;61:140-45. doi: 10.1016/S0025-6196(12)65200-8.
- Edwards F.C., Truelove S.C. The course and prognosis of ulcerative colitis. iii. Complications. Gut. 1964;5:1-22. doi: 10.1136/gut.5.1.1.
- Koenigs K.P., McPhedran P., Spiro H.M. Thrombosis in inflammatory bowel disease. J Clin Gastroenterol. 1987;9:627-31. doi: 10.1097/00004836198712000-00004.
- Sloan W.P., Bargen J.A., Gage R.P. Life histories of patients with chronic ulcerative colitis: a review of 2,000 cases. Gastroenterology. 1950;16:25-38.
- Ricketts W.E., Palmer W.L. Complications of chronic non-specifi ulcerative colitis. Gastroenterology 1946;7:55-66.
- Graef V., Baggenstoss A.H., Sauer W.G., Spittel J.A. Jr. Venous thrombosis in non-specific ulcerative colitis. A necropsy study. Arch intern Med. 1965;117:377-82. doi: 10.1001/archi nte.1966.03870090061010.
- Johns D.R. Cerebrovascular complications of inflammatory bowel disease. Am J Gastroenterol. 1991;86:367-70.
- Katsanos A.H., Kosmidou M., Giannopoulos S., et al. Cerebral arterial infarction in inflammatory bowel diseases. Eur J intern Med. 2014;25:37-44. doi: 10.1016/j.ejim.2013.08.702.
- Prior A., Strang F.A., Whorwell P.J. internal carotid artery occlusion in association with Crohn's disease. Dig Dis Sci. 1987;32:1047-50. Doi: 10.1007/ BF01297197.
- Landman C., Nahon S., Cosnes J., et al. Portomesenteric vein thrombosis in patients with inflammatory bowel disease. inflamm Bowel Dis. 2013;19:582-89.
- Maccini D.M., Berg J.C., Bell G.A. Budd-Chiari syndrome and Crohn's disease. An unreported association. Dig Dis Sci. 1989;34:1933-36. doi: 10.1007/BF01536715.
- Stapleton S.R., Curley R.K., Simpson W.A. Cutaneous gangrene secondary to focal thrombosis-an important cutaneous manifestation of ulcerative colitis. Clin Exp Dermatol. 1989;14:387-89. doi: 10.1111/j.1365-2230.1989. tb02594.x.
- Schneiderman J.H., Sharpe J.A., Sutton D.M. Cerebral and retinal vascular complications of inflammatory bowel disease. Ann Neurol. 1979;5:331-37. doi: 10.1002/ana.410050405.
- Keyser B.J., Hass A.N. Retinal vascular disease in ulcerative colitis. Am J Ophthalmol. 1994;118:395-96.
- Vayalambrone D., Ivanova T., Misra A. Nonischemic central retinal vein occlusion in an adolescent patient with ulcerative colitis. Case Rep Ophthalmol Med. 2011;2011:963583. doi: 10.1155/2011/963583.
- Mutlu B., Ermeydan C.M., Enç F, et al. Acute myocardial infarction in a young woman with severe ulcerative colitis. int J Cardiol. 2002;83:183-85. doi: 10.1016/S01 67-52 73(02)00043-8.
- Murthy S.K., Nguyen G.C. Venous thromboembolism in inflammatory bowel disease: an epidemiological review. Am J Gastroenterol. 2011;106:713-18. doi: 10.1038/ajg.2011.53.
- Bernstein C.N., Blanchard J.F., Houston D.S., Wajda A. The incidence of deep venous thrombosis and pulmonary embolism among patients with inflammatory bowel disease: a population-based cohort study. Thromb Haemost. 2001; 85:430-34.
- Miehsler W., Reinisch W., Valic E., et al. is inflammatory bowel disease an independent and disease specifi risk factor for thromboembolism? Gut. 2004;53:542-48. Doi: 10.1136/ gut.2003.025411].
- Huerta C., Johansson S., Wallander M.A., Garcia Rodriguez L.A. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch intern Med. 2007;167:935-43. doi: 10.1001/archinte.167.9.935.
- Kappelman M.D., Horvath-Puho E., Sandler R.S., et al. Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut. 2011;60:937-43. Doi: 10.1136/ gut.2010.228585.
- Grainge M.J., West J., Card T.R. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657-63. Doi: 10.1016/ S0140-6736(09)61963-2.
- Bernstein C.N., Nabalamba A. Hospitalization-based major comorbidity of inflammatory bowel disease in Canada. Can J Gastroenterol. 2007;21:507-11.
- Nguyen G.C., Sam J. Rising prevalence of venous thromboembolism and its impact on mortality among hospitalized inflammatory bowel disease patients. Am J Gastroenterol. 2008;103:2272 80. doi: 10.1111/j.1572-0241.2008.02052.x
- Saleh T., Matta F., Yaekoub A.Y., et al. Risk of venous thromboembolism with inflammatory bowel disease. Clin Appl Thromb Hemost. 2011;17:254 58. doi: 10.1177/1076029609360528
- Rothberg M.B., Lindenauer P.K., Lahti M., et al. Risk factor model to predict venous thromboembolism in hospitalized medical patients. J Hosp Med. 2011;6:202-9. doi: 10.1002/jhm.888.
- Sridhar A.R., Parasa S., Navaneethan U., et al. Comprehensive study of cardiovascular morbidity in hospitalized inflammatory bowel disease patients. J Crohns Colitis. 2011;5:287-94. doi: 10.1016/j.crohns.2011.01.011.
- Nguyen G.C., Boudreau H., Harris M.L., Maxwell C.V. Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States. Clin Gastroenterol Hepatol. 2009;7:329-34. Doi: 10.1016/j. cgh.2008.10.022.
- Bröms G., Granath F., Linder M., et al. Complications from inflammatory bowel disease during pregnancy and delivery. Clin Gastroenterol Hepatol. 2012;10:1246-52. Doi: 10.1016/j. cgh.2012.08.018.
- Merrill A., Millham F. increased risk of postoperative deep vein thrombosis and pulmonary embolism in patients with inflammatory bowel disease: a study of National Surgical Quality improvement Program patients. Arch Surg. 2012;147:120-24. doi: 10.1001/archsurg.2011.297.
- Wallaert J.B., De Martino R.R., Marsicovetere P.S., et al. Venous thromboembolism after surgery for inflammatory bowel disease: are there modifiable risk factors? Data from ACS NSQiP. Dis Colon Rectum. 2012;55:1138-44. Doi: 10.1097/ DCR.0b013e3182698f60.
- Nylund C.M., Goudie A., Garza J.M., et al. Venous thrombotic events in hospitalized children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013;56:485-91.
- Yuhara H., Steinmaus C., Corley D., et al. Metaanalysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013;37:953-62.
- Papay P., Miehsler W., Tilg H., et al. Clinical presentation of venous thromboembolism in inflammatory bowel disease. J Crohns Colitis. 2013;7:723-29. Doi: 10.1016/j. crohns.2012.10.008.
- Grip O., Svensson P.J., Lindgren S. inflammatory bowel disease promotes venous thrombosis earlier in life. Scand J Gastroenterol. 2000;35:619-23. doi: 10.1080/003655200750 023589.
- Jackson L.M., O'Gorman PJ., O'Connell J., et al. Thrombosis in inflammatory bowel disease: clinical setting, procoagulant profile and factor V Leiden. QJM. 1997;90:183-88. Doi: 10.1093/ qjmed/90.3.183.
- Solem C.A., Loftus E.V., Tremaine W.J., Sandborn W.J. Venous thromboembolism in inflammatory bowel disease. Am J Gastroenterol. 2004;99:97-101. Doi: 10.1046/ j.1572-0241.2003.04026.x.
- Jess T., Gamborg M., Munkholm P., Serensen T.I. Overall and cause-specifi mortality in ulcerative colitis: meta-analysis of population-based inception cohort studies. Am J Gastroenterol. 2007;102:609-17. doi: 10.1111/j.1572- 0241.2006.01000.x.
- Duricova D., Pedersen N., Elkjaer M., et al. Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies. inflamm Bowel Dis. 2010;16:347-53.
- O'Connor O.J., Cahill R.A., Kirwan W.O., Redmond H.P. The incidence of postoperative venous thrombosis among patients with ulcerative colitis. ir J Med Sci. 2005;174:20-2. Doi: 10.1007/ BF03169142.
- Danese S., Papa A., Saibeni S., et al. inflammation and coagulation in inflammatory bowel disease: The clot thickens. Am J Gastroenterol. 2007;102:174 86. doi: 10.1111/j.1572-0241.2006.00943.x
- Nogami H., iiai T, Maruyama S., et al. Common carotid arterial thrombosis associated with ulcerative colitis. World J Gastroenterol. 2007;13:1755-57.
- Richard S., Mione G., Perrin J., et al. internal carotid thrombus in patients with inflammatory bowel disease: two cases. World J Gastroenterol. 2013;19:773- 75. doi: 10.3748/wjg.v19.i5.773.
- Irving P.M., Alstead E.M., Greaves R.R., et al. Acute mesenteric infarction: an important cause of abdominal pain in ulcerative colitis. Eur J Gastroenterol Hepatol. 2005;17:1429-32. Doi: 10.109 7/00042 737-200512000-0002 7.
- Szychta P., Reix T., Sevestre M.A., et al. Aortic thrombosis and ulcerative colitis. Ann Vasc Surg. 2001;15:402-4. Doi: 10.1007/ s100160010068.
- Novacek G, Haumer M., Schima W., et al. Aortic mural thrombi in patients with inflammatory bowel disease: report of two cases and review of the literature. inflamm Bowel Dis. 2004;10:430-35. doi: 10.1097/00054725-200407000-00016.
- Levy P.J., Tabares A.H., Olin J.W. Lower extremity arterial occlusions in young patients with Crohn's colitis and premature atherosclerosis: report of six cases. Am J Gastroenterol. 1997;92:494-97.
- Haumer M., Teml A., Dirisamer A., et al. Severe ulcerative colitis complicated by an arterial thrombus in the brachiocephalic trunk. inflamm Bowel Dis. 2007;13:937-38. Doi: 10.1002/ ibd.20116].
- Di Fabio F., Obrand D., Satin R., Gordon P.H. intraabdominal venous and arterial thromboembolism in inflammatory bowel disease. Dis Colon Rectum. 2009;52:336-42. Doi: 10.1007/ DCR.0b013e31819a235d.
- Ha C., Magowan S., Accortt N.A., et al. Risk of arterial thrombotic events in inflammatory bowel disease. Am J Gastroenterol. 2009;104:1445-51. doi: 10.1038/ajg.2009.81.
- Kristensen S.L., Ahlehoff O., Lindhardsen J., et al. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death - a Danish nationwide cohort study. PLoS One. 2013;8:e56944. doi: 10.1371/journal. pone.0056944eb.
- Andersohn F., Waring M., Garbe E. Risk of ischemic stroke in patients with Crohn's disease: a population-based nested case-control study. inflamm Bowel Dis. 2010;16:1387-92. doi: 10.1002/ibd.21187.
- Bernstein C.N., Wajda A., Blanchard J.F. The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study. Clin Gastroenterol Hepatol. 2008;6:41-5. doi: 10.1016/j.cgh.2007.09.016.
- Yarur A.J., Deshpande A.R., Pechman D.M., et al. inflammatory bowel disease is associated with an increased incidence of cardiovascular events. Am J Gastroenterol. 2011;106:741-47. Doi: 10.1038/ ajg.2011.63.
- Rungoe C., Basit S., Ranthe M.F., et al. Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study. Gut. 2013;62:689-94. Doi: 10.1136/ gutjnl-2012-303285.
- Zöller B., Li X., Sundquist J., Sundquist K. Risk of subsequent ischemic and hemorrhagic stroke in patients hospitalized for immune-mediated diseases: a nationwide follow-up study from Sweden. BMC Neurol. 2012;12:41. doi: 10.1186/1471-2377-12-41.
- Singh S., Singh H., Loftus E.V., Pardi D.S. Risk of cerebrovascular accidents and ischemic heart disease in patients with inflammatory bowel disease: a systematic review and metaanalysis. Clin Gastroenterol Hepatol. 2014;12:382-93. doi: 10.1016/j.cgh.2013.08.023.
- Dorn S.D., Sandler R.S. inflammatory bowel disease is not a risk factor for cardiovascular disease mortality: results from a systematic review and meta-analysis. Am J Gastroenterol. 2007;102:662-67. Doi: 10.1111/ j.1572- 0241.2006.01018.x.
- Osterman M.T., Yang Y.X., Brensinger C., et al. No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease. Clin Gastroenterol Hepatol. 2011;9:875-80. doi: 10.1016/j.cgh.2011.06.032.
- Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133:381S-453S. doi: 10.1378/chest. 08-0656.
- Kornbluth A., Sachar D.B. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105:501-23; quiz 524. doi: 10.1038/ajg.2009.727.
- Mowat C., Cole A., Windsor A., et al. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011;60:571-607. Doi: 10.1136/ gut.2010.224154.
- Bitton A., Buie D., Enns R., et al. Treatment of hospitalized adult patients with severe ulcerative colitis: Toronto consensus statements. Am J Gastroenterol. 2012;107:179-94. Doi: 10.1038/ ajg.2011.386.
- Van Assche G., Dignass A., Bokemeyer B., et al. Second European evidencebased consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013;7:1 33. doi: 10.1016/j.crohns.2012.09.005
- Harbord M., Annese V., Vavricka S.R., et al.; The First European Evidence-based Consensus on Extra-intestinal Manifestations in inflammatory Bowel Disease. J Crohn's Colitis. 2016;10(3):239 54. doi: 10.1093/ecco-jcc/jjv213
- Folwaczny C., Wiebecke B., Loeschke K. Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease. Am J Gastroenterol. 1999;94:1551-55
- Ang Y.S., Mahmud N., White B., et al. Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease. Aliment Pharmacol Ther. 2000;14:1015 22
- Bloom S., Kiilerich S., Lassen M.R., et al. Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis. Aliment Pharmacol Ther. 2004;19:871-78
- Pastorelli L., Saibeni S., Spina L., et al. Oral, colonic-release low-molecularweight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis. Aliment Pharmacol Ther. 2008;28:581-88. doi: 10.1111/j.1365-2036.2008.03757.x
- Shen J., Ran Z.H., Tong J.L., Xiao S.D. Metaanalysis: The utility and safety of heparin in the treatment of active ulcerative colitis. Aliment Pharmacol Ther. 2007;26:653-63.
- Ra G., Thanabalan R., Ratneswaran S., Nguyen G.C. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients. J Crohns Colitis. 2013;7:e479-e485. Doi:10.1016/j. crohns.2013.03.002.
- Nguyen G.C., Wu H., Gulamhusein A., et al. The utility of screening for asymptomatic lower extremity deep venous thrombosis during inflammatory bowel disease flares: a pilot study. inflamm Bowel Dis. 2013;19:1053-58. doi: 10.1097/MiB.0b013e3182802a65.
- Bryant R.V., Jairath V., Curry N., Travis S.P. Thrombosis in inflammatory bowel disease: are we tailoring prophylaxis to those most at risk? J Crohns Colitis. 2014;8:166-71. Doi: 10.1016/j. crohns.2013.09.007.
- Nguyen G.C. IBD: postoperative VTE prophylaxis in iBD. Nat Rev Gastroenterol Hepatol. 2013;10:5-6. doi: 10.1038/nrgastro.2012.233.
- Scarpa M., Pilon F., Pengo V., et al. Deep venous thrombosis after surgery for inflammatory bowel disease: is standard dose low molecular weight heparin prophylaxis enough? World J Surg 2010;34:1629-36. doi: 10.1007/s00268-010-0490-8.
- Nguyen G.C., Yeo E.L. Prophylaxis of venous thromboembolism in iBD. Lancet. 2010;375:616 17. doi: 10.1016/S0140-6736(10)60174-2
- Zitomersky N.L., Verhave M., Trenor C.C. Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention. inflamm Bowel Dis. 2011;17:458-70. Doi: 10.1002/ ibd.21334.
- Tabibian J.H., Streiff M.B. inflammatory bowel disease-associated thromboembolism: a systematic review of outcomes with anticoagulation versus catheter-directed thrombolysis. inflamm Bowel Dis. 2012;18:161-71. doi: 10.1002/ibd.21307.
- Nguyen G.C., Bernstein C.N. Duration of anticoagulation for the management of venous thromboembolism in inflammatory bowel disease: a decision analysis. Am J Gastroenterol. 2013;108:1486-95. Doi: 10.1038/ ajg.2013.220.
- van der Hulle T, Kooiman J., den Exter P.L., et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost. 2014;12:320 28. doi: 10.1111/jth.12485
- Razik R., Bernstein C.N., Sam J., et al. Survey of perceptions and practices among Canadian gastroenterologists regarding the prevention of venous thromboembolism for hospitalized inflammatory bowel disease patients. Can J Gastroenterol. 2012;26:795-98.
- Sam J.J., Bernstein C.N., Razik R., et al. Physicians' perceptions of risks and practices in venous thromboembolism prophylaxis in inflammatory bowel disease. Dig Dis Sci. 2013;58:46-52. Doi: 10.1007/ s10620-012-2435-6.
- Tinsley A., Naymagon S., Enomoto L.M., et al. Rates of pharmacologic venous thromboembolism prophylaxis in hospitalized patients with active ulcerative colitis: results from a tertiary care center. J Crohns Colitis. 2013;7:e635-e640. Doi: 10.1016/ j.crohns.2013. 05.002.
- Allen J.I. Mind the gap: venous thromboembolism prophylaxis in patients hospitalized with inflammatory bowel disease. Dig Dis Sci. 2013;58:1-4. doi: 10.1007/s10620-012- 2492-x.
- Nguyen G.C., Bernstein C.N., Bitton A., et al. Consensus statements on the risk, prevention, and treatment of venous thromboembolism in inflammatory bowel disease: Canadian Association of Gastroenterology. Gastroenterology. 2014;146:835-48. Doi: 10.1053/j. gastro.2014.01.042.